SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.20
+1.30 (1.67%)
Sep 5, 2025, 1:42 PM CST

SunWay Biotech Co., LTD. Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
84.86118.5746.0930.04168.76125.71
Upgrade
Depreciation & Amortization
77.3882.4623.676.419.6220.09
Upgrade
Other Amortization
1.131.131.241.360.110.25
Upgrade
Loss (Gain) From Sale of Assets
-0.2-----
Upgrade
Asset Writedown & Restructuring Costs
----0.140.11
Upgrade
Loss (Gain) on Equity Investments
-0.340.04----
Upgrade
Stock-Based Compensation
----0.290.23
Upgrade
Provision & Write-off of Bad Debts
--0.62-0.360.45-
Upgrade
Other Operating Activities
-7.261.93-1.626.741.45-0.02
Upgrade
Change in Accounts Receivable
26.94-65.595.23-43.72-56.92-1.99
Upgrade
Change in Inventory
-45.63-39.819.91-5.9713.1115.03
Upgrade
Change in Accounts Payable
-0.6326.16-36.2533.64-0.63-0.54
Upgrade
Change in Unearned Revenue
-8.22-2.240.286.75-3.110.55
Upgrade
Change in Other Net Operating Assets
74.9334.276.817.7117.522.44
Upgrade
Operating Cash Flow
202.97156.9255.9842.58160.76181.86
Upgrade
Operating Cash Flow Growth
151.24%180.30%31.47%-73.51%-11.60%140.68%
Upgrade
Capital Expenditures
-103.04-116.19-46.24--9.71-1.56
Upgrade
Sale of Property, Plant & Equipment
0.2-----
Upgrade
Cash Acquisitions
--293.22---
Upgrade
Sale (Purchase) of Intangibles
-1.43-7.49--1.52-0.09-0.15
Upgrade
Investment in Securities
--1.39----
Upgrade
Other Investing Activities
-0.31-0.73-28.21-1.96-1.06-0.51
Upgrade
Investing Cash Flow
-104.58-125.8218.78-3.48-10.86-2.21
Upgrade
Short-Term Debt Issued
----50-
Upgrade
Total Debt Issued
307.19---50-
Upgrade
Short-Term Debt Repaid
--7.51-58.06-52.51-50-
Upgrade
Long-Term Debt Repaid
--32.64-11.25-1.38-9.88-9.29
Upgrade
Total Debt Repaid
-34.87-40.15-69.31-53.9-59.88-9.29
Upgrade
Net Debt Issued (Repaid)
272.32-40.15-69.31-53.9-9.88-9.29
Upgrade
Issuance of Common Stock
--76.5704.257.15
Upgrade
Repurchase of Common Stock
-1.53---15--
Upgrade
Common Dividends Paid
--59.39-42.65-6.44-92.73-
Upgrade
Other Financing Activities
-0.26-0.26---2.45
Upgrade
Financing Cash Flow
270.53-99.8-35.46-5.33-98.450.31
Upgrade
Foreign Exchange Rate Adjustments
-0.210.19-0.68--0.40.03
Upgrade
Net Cash Flow
368.72-68.49238.6233.7751.1230
Upgrade
Free Cash Flow
99.9340.739.7542.58151.05180.3
Upgrade
Free Cash Flow Growth
-317.89%-77.11%-71.81%-16.22%141.43%
Upgrade
Free Cash Flow Margin
10.50%4.20%1.71%10.01%39.70%57.34%
Upgrade
Free Cash Flow Per Share
1.650.670.322.114.405.55
Upgrade
Cash Interest Paid
5.545.542.091.320.090.2
Upgrade
Cash Income Tax Paid
21.5221.5211.762.88--
Upgrade
Levered Free Cash Flow
143.145.4-78.44-43.7785.6132.9
Upgrade
Unlevered Free Cash Flow
146.378.87-77.13-43.0585.66133.03
Upgrade
Change in Working Capital
47.4-47.21-14.02-1.59-30.0535.49
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.